First Dallas Securities Inc. Sells 250 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

First Dallas Securities Inc. trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 900 shares of the medical equipment provider’s stock after selling 250 shares during the period. First Dallas Securities Inc.’s holdings in Intuitive Surgical were worth $470,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of ISRG. Patron Partners LLC grew its stake in Intuitive Surgical by 3.7% during the fourth quarter. Patron Partners LLC now owns 1,890 shares of the medical equipment provider’s stock valued at $987,000 after acquiring an additional 67 shares in the last quarter. Trust Point Inc. increased its holdings in shares of Intuitive Surgical by 7.7% in the fourth quarter. Trust Point Inc. now owns 2,262 shares of the medical equipment provider’s stock worth $1,181,000 after purchasing an additional 162 shares during the last quarter. Alliance Wealth Advisors LLC UT purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $278,000. Optas LLC boosted its stake in Intuitive Surgical by 22.1% during the fourth quarter. Optas LLC now owns 795 shares of the medical equipment provider’s stock valued at $415,000 after buying an additional 144 shares during the last quarter. Finally, Financial Life Planners bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $81,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jamie Samath sold 269 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the transaction, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,727,816.73. This trade represents a 2.98 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 28,843 shares of company stock valued at $15,357,560. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $578.55 on Tuesday. The firm has a market cap of $206.07 billion, a P/E ratio of 90.26, a P/E/G ratio of 5.51 and a beta of 1.39. The firm has a 50-day simple moving average of $550.40 and a 200-day simple moving average of $510.02. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. BTIG Research boosted their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Evercore ISI increased their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Raymond James boosted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Royal Bank of Canada lifted their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.